Therapeutic vaccination against chronic viral infections.
Chronic viral infections such as those caused by hepatitis B virus, human papilloma virus, herpes simplex virus, and HIV, in theory, present logical targets of active specific immunotherapy. Indeed, immunological mechanisms are involved in several aspects of their pathogenesis and natural course, such as virus persistence, destruction of infected cells and control of viral replication. Therapeutic vaccination could therefore be an adequate replacement for, or adjunct to, existing therapies. Almost all approaches to therapeutic vaccination have been evaluated in those four disease areas. Despite encouraging results in animals none of these attempts has, so far, been completely successful in the human setting. However, with a better understanding of the immunological mechanisms involved in the control of disease successful therapeutic vaccines, used alone or in combination with other therapies, are an achievable goal.
Vandepapelière
Pierre
P
Clinical R&D HIV vaccines and anti-infective therapeutic vaccines, GlaxoSmithKline Biologicals, Rue de l'Institut 89, B-1330, Rixensart, Belgium. pierre.vandepapeliere@gskbio.com
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D007167:Immunotherapy; D014611:Vaccination; D019562:Viral Load; D014777:Virus Diseases / Q000209:etiology / Q000517:prevention & control / Q000628:therapy
D000998:Antiviral Agents